ClinCalc Pro
Menu
PTHrP analogue (anabolic)

Abaloparatide

Brand names: Eladynos

Adult dose

Dose: 80 micrograms
Route: Subcutaneous
Frequency: Once daily for max 18 months

Clinical pearls

  • For postmenopausal osteoporosis at high fracture risk
  • Follow with antiresorptive on completion

Contraindications

  • Pre-existing hypercalcaemia
  • Severe renal impairment
  • Prior skeletal radiotherapy
  • Bone metastases
  • Paget disease

Side effects

  • Hypercalcaemia
  • Palpitations
  • Dizziness
  • Nausea
  • Injection site reaction

Interactions

  • Cardiac glycosides (monitor)
  • Loop diuretics

Monitoring

  • Serum and urinary calcium
  • BMD
  • BP/HR

Reference: BNF; NICE TA991; SmPC Eladynos. Verify against your local formulary and the latest BNF before prescribing.

Related

Curated clinical cross-links plus same-class fallbacks.